Skip to main content
. 2021 Oct 8;10(19):4606. doi: 10.3390/jcm10194606

Figure 3.

Figure 3

Proportion of convalescent patients with no detectable SARS-CoV-2 reactive T cells as determined by ELISpot analysis (n = 30) after stimulation with the various S-peptide pools with regard to primary COVID-19 severity [n (%)].